Placental Histomorphological and Radiological Changes and Their Association with Maternal Insulin Resistance in Gestational Diabetes Mellitus.

Authors

  • Naveera Naveed
  • Aliya Shabbir
  • Aleena Younis
  • Najam-ul-Sehar Javed
  • Roomi Memon
  • Naeem Shahzad

DOI:

https://doi.org/10.63682/jns.v14i33S.10255

Keywords:

Gestational Diabetes Mellitus, Placenta, Histomorphology, Radiology, Insulin Resistance, HOMA-IR, Chorangiosis, Syncytial Knots

Abstract

Background: Gestational Diabetes Mellitus (GDM) is associated with maternal metabolic disturbances, particularly insulin resistance, leading to structural and functional alterations in the placenta. These changes can be evaluated through histomorphological and radiological assessment.

Objective: To evaluate placental histomorphological and radiological changes in GDM and determine their association with maternal insulin resistance.

Methods: This comparative cross-sectional study included 80 pregnant women (40 diagnosed with GDM and 40 normoglycemic controls). Maternal insulin resistance was assessed using the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR). Antenatal placental evaluation was performed using obstetric ultrasonography, assessing placental thickness, grading, and vascularity. Placental tissues were collected after delivery and examined histologically for villous immaturity, syncytial knots, fibrinoid necrosis, chorangiosis, and intervillous hemorrhage.

Results: Radiological assessment revealed significantly increased placental thickness in the GDM group (4.6 ± 0.7 cm) compared to controls (3.8 ± 0.5 cm, p < 0.001). Advanced placental grading (Grade III before 37 weeks) was observed in 42.5% of GDM cases versus 12.5% of controls (p = 0.002). Increased placental vascularity on Doppler was noted in 60% of GDM cases compared to 22.5% in controls (p < 0.001).

Histologically, syncytial knots were present in 72.5% of GDM placentae versus 32.5% of controls (p < 0.001), villous immaturity in 65% vs 27.5% (p = 0.002), chorangiosis in 55% vs 20% (p = 0.001), fibrinoid necrosis in 60% vs 25% (p = 0.003), and intervillous hemorrhage in 47.5% vs 17.5% (p = 0.004).

Mean HOMA-IR levels were significantly higher in the GDM group (4.8 ± 1.2) compared to controls (2.1 ± 0.9, p < 0.001). A strong positive correlation was observed between HOMA-IR and placental thickness (r = 0.59), vascularity (r = 0.61), syncytial knot density (r = 0.62), and villous immaturity (r = 0.58), all statistically significant (p < 0.01).

Conclusion: GDM is associated with significant radiological and histomorphological placental alterations, strongly correlated with maternal insulin resistance. Combined imaging and histological evaluation provides a comprehensive understanding of placental pathology in GDM and may aid in early identification of high-risk pregnancies and improved maternal-fetal outcomes..

Downloads

Download data is not yet available.

References

American Diabetes Association. Standards of care in diabetes—2023. Diabetes Care. 2023;46(Suppl 1):S254–S266.

2. McIntyre HD, Catalano P, Zhang C, et al. Gestational diabetes mellitus. Nat Rev Dis Primers. 2021;7(1):47.

3. Burton GJ, Fowden AL. The placenta: a multifaceted organ. Philos Trans R Soc Lond B Biol Sci. 2021;376:20200133.

4. Plows JF, Stanley JL, Baker PN, et al. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2021;22(7):3542.

5. Nadeem L, Munir S, et al. Role of oxidative stress in GDM placenta. Front Endocrinol. 2023;14:1102345.

6. Pantham P, Aye IL, Powell TL. Inflammation in GDM. Front Endocrinol. 2021;12:645312.

7. Huynh J, Dawson D, Roberts D, et al. Placental pathology in GDM. Placenta. 2022;117:76–83.

8. Al-Amin A, Othman H, et al. Ultrasound markers of placental dysfunction in GDM. J Ultrasound Med. 2022;41(5):1201–1210.

9. Daskalakis G, et al. Doppler studies in GDM pregnancies. J Matern Fetal Neonatal Med. 2022;35(12):2254–2260.

10. HAPO Study Cooperative Research Group. Hyperglycemia and pregnancy outcomes revisited. Diabetes Care. 2021;44:2008–2015.

11. Lowe WL Jr, Scholtens DM, et al. Long-term metabolic outcomes in offspring of GDM. JAMA. 2022;327(7):677–688.

12. Higgins M, McAuliffe F. Placental function in maternal metabolic disorders. Front Endocrinol. 2022;13:812345.

13. Sibiak R, Jankowski M, Gutaj P, et al. Placental dysfunction in GDM. Int J Environ Res Public Health. 2022;19:1447.

14. Jarmuzek P, Wielgos M, Bomba-Opon D. Placental pathologic changes in GDM. Ginekol Pol. 2021;92(2):94–99.

15. Desoye G, Nolan CJ. The fetal glucose steal. Diabetologia. 2021;64(10):2190–2201.

16. World Health Organization. Diagnostic criteria for hyperglycemia in pregnancy. WHO; 2022.

Downloads

Published

2025-12-12

How to Cite

1.
Naveed N, Shabbir A, Younis A, Javed N- ul-S, Memon R, Shahzad N. Placental Histomorphological and Radiological Changes and Their Association with Maternal Insulin Resistance in Gestational Diabetes Mellitus. J Neonatal Surg [Internet]. 2025 Dec. 12 [cited 2026 May 9];14(33S):1058-64. Available from: https://jneonatalsurg.com/index.php/jns/article/view/10255

Issue

Vol. 14 No. 33S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.